|
Match
|
Document |
Document Title |
|
|
8182807 |
Method for inhibiting reperfusion injury in the brain
The present invention relates to a method for inhibiting reperfusion injury in the brain. The method involve injecting via the carotid artery or jugular vein an antioxidant-loaded nanoparticle. A...
|
|
|
8182825 |
Message energy memory ceramics
The present invention provides a message energy memory ceramics. The message information memory ceramics includes: (1) a plurality of message energy memory ceramics grains composed of a silicon...
|
|
|
8182839 |
Production of cellulose nanoparticles
The present invention relates to novel nanoparticles based on cellulose and a process for producing them and their use.
|
|
|
8182792 |
Pharmaceutical compositions
A process for micronization of pharmaceutically active agents.
|
|
|
8182800 |
Metal ion modified high surface area materials for odor removal and control
This invention relates to high surface area materials, such as nanoparticles, that are coated with metal ions. These modified nanoparticles have active sites that bind various gases and/or odorous...
|
|
|
8182838 |
Dry powder composition comprising co-jet milled particles for pulmonary inhalation
The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically...
|
|
|
8182791 |
Formulations for use in inhaler devices
A formulation for an inhaler device comprises carrier particles having a diameter of at least 50 μm and a mass median diameter of at least 175 μm; active particles; and additive material to which i...
|
|
|
8183290 |
Pharmaceutically acceptable propylene glycol solvate of naproxen
The invention relates to pharmaceutical compositions comprising propylene glycol solvates of APIs. In particular a 2:1 complex of naproxen sodium to propylene glycol is disclosed which is a...
|
|
|
8178124 |
Drug carrier and drug carrier kit for inhibiting fibrosis
An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a...
|
|
|
8178112 |
Ketoprofen compositions and methods of making them
A wide variety of pharmaceutically and commercially acceptable dosage forms of ketoprofen are prepared by dissolving ketoprofen in pharmaceutically acceptable solvents.
|
|
|
8178081 |
Method for reducing odor using coordinated polydentate compounds
A method for reducing odor is provided. The method comprises forming a coordination complex between a transition metal and a polydentate compound, and contacting the coordinated complex with an...
|
|
|
8178129 |
Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
The invention provides a formulation of water insoluble or poorly water soluble drugs encapsulated in lipidated glycosaminoglycan particles for targeted drug delivery.
|
|
|
8173170 |
Drug carrier and drug carrier kit for inhibiting fibrosis
An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a...
|
|
|
8173171 |
Hydrogel microparticle composition, application thereof and method for preparing the same
Disclosed herein is a method for preparing a hydrogel microparticle composition. A dispersion including 1 part by weight of N-isopropyl acrylamide, about 0.1-0.5 part by weight of chitosan, about...
|
|
|
8173167 |
Micelle composition of polymer and passenger drug
Hydrophobic drugs become more practical for treatments by being encapsulated in micelle compositions for increasing solubility. Micelle compositions may include an excipient tocopherol and/or...
|
|
|
8173166 |
Methods of producing tungsten nanoparticles
The present teachings are directed methods of producing tungsten-containing nanoparticles, specifically tungsten nanoparticles and tungsten oxide nanoparticles with an average particle size of less...
|
|
|
8173173 |
Anhdyrous lactose agglomerates and the preparation thereof
The invention relates to a process for the preparation of anhydrous lactose agglomerates, said process comprising (i) subjecting essentially anhydrous lactose primary particles comprising at least...
|
|
|
8173164 |
Oral administration forms for administering a fixed tramadol and diclofenac combination
An oral administration unit containing the active substances Tramadol and Diclofenac and/or physiologically acceptable salts thereof, in which both active substances are contained in the same...
|
|
|
8173637 |
Stabilized atypical antipsychotic formulation
A pharmaceutical composition that contains an atypical antipsychotic drug and succinic acid, fumaric acid or a mixture of succinic acid and fumaric acid.
|
|
|
8173172 |
Preparation of powder agglomerates
The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous...
|
|
|
8173168 |
Dispersible macromolecule compositions and methods for their preparation and use
A process for preparing ultrafine powders of biological macromolecules comprises atomizing liquid solutions of the macromolecules, drying the droplets formed in the atomization step, and collecting...
|
|
|
8173107 |
Delivery of antipsychotics through an inhalation route
The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a...
|
|
|
8173165 |
Water-dispersible pellets
A water-dispersible particle for delivery of nitrogen to a plant is disclosed. The water-dispersible particle also delivers an active ingredient such as a plant hormone to a desirable plant or a...
|
|
|
8173169 |
Formulation and process for the preparation of modafinil
The present invention provides pharmaceutical tablets comprising modafinil particles, processes for preparing such pharmaceutical tablets, and methods of treating a disease or disorder using the...
|
|
|
8168227 |
Modified powder and cosmetic composition using the same
The present invention provides a modified powder that is obtainable by coating the surface of a base powder with a hydrophobizing agent and a cationic surfactant. In the modified powder described...
|
|
|
8168223 |
Engineered particles and methods of use
Engineered particles are provided may be used for the delivery of a bioactive agent to the respiratory tract of a patient. The particles may be used in the form of dry powders or in the form of...
|
|
|
8168224 |
Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof
The present disclosure relates to a kind of sodium alginate microsphere vascular embolus that contains water-soluble drug and preparation and application thereof. The embolus preparation falls into...
|
|
|
8168225 |
Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients
The invention relates to microcapsules, and a continuous micro-encapsulation water-in-oil-in-water microencapsulation process through in situ and interfacial polymerization of the emulsion. The...
|
|
|
8168226 |
Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.
|
|
|
8168674 |
Method for treating bronchial diseases
Administration of a loop diuretic in nebulized dry powder form directly to a patient's lungs for treating bronchial disease.
|
|
|
8168629 |
Analgesic combination of tramadol and meloxicam
Disclosed is a pharmaceutical composition, comprising a combination of a dose of meloxicam or a pharmaceutically acceptable salt thereof and a dose of tramadol or a pharmaceutically acceptable salt...
|
|
|
8163307 |
Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof
The invention discloses a pharmaceutical composition for the controlled release of relatively toxic active compounds, in particular for bioactive proteins from the class of interferons. The...
|
|
|
8163299 |
Stabilized pharmaceutical product
Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar.
|
|
|
8163271 |
Oral hygiene products and method of using the same
The present invention is directed towards a composition for highly efficient and quick plaque and tartar removal and inhibition including pure ascorbic acid crystals and/or granulars (vitamin C)...
|
|
|
8163312 |
Herbal formulation for prevention and treatment of diabetes and associated complications
An herbal formulation for prevention and treatment of Diabetes and associated complications comprising extracts from selected Indian medicinal herbs. The invention has associate formulations for...
|
|
|
8158153 |
Nanoparticulate bisphosphonate compositions
Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal.
|
|
|
8158155 |
Odor control cellulose-based granules
A cellulose-based granule that functions as a carrier vehicle for an odor control agent is described. The granule has a relatively porous substrate body having a high-surface area of at least about...
|
|
|
8158154 |
Nasal pharmaceutical formulations and methods of using the same
Nasal pharmaceutical formulations comprising a drug substance having a specific particle size distribution profile are disclosed herein. Such profile provides increased bioavailability, increased...
|
|
|
8158110 |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
The present invention relates to methods and compositions for prevention of graft rejection in lung transplant recipients and for treatment of subjects with pulmonary disorders. Specifically, the...
|
|
|
8158152 |
Lyophilization process and products obtained thereby
A lyophilization process which comprises dissolving a material in one or more solvents for said material to form a solution; forcing said material at least partially out of solution by combining...
|
|
|
8153157 |
Porous cellulose aggregate and molding composition thereof
A porous cellulose aggregate characterized by having a secondary aggregate structure resulting from aggregation of primary cellulose particles, having a pore volume within a particle of 0.265 to...
|
|
|
8153158 |
Tissue substitutes comprising stem cells and reduced ceria
A biocompatible composite includes a solid biocompatible material and a plurality of living human progenitor or living stem cells attached thereto. The composition resulting in accelerated repair...
|
|
|
8153159 |
Modafinil modified release pharmaceutical compositions
Pharmaceutical compositions comprising modafinil. The pharmaceutical compositions can have a release profile which is different than that of traditional pharmaceutical compositions of modafinil.
|
|
|
8153156 |
Hydrogel nanocompsites for ophthalmic applications
The present invention relates to reversible hydrogel systems. Particularly, the hydrogel of the present invention is made up of copolymers that can be a hydrogel when in an oxidize state and can be...
|
|
|
8153104 |
Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of...
|
|
|
8147802 |
Chelator-functionalized nanoparticles
Provided herein are chelator-functionalized nanoparticles comprising a passive core; and an active coating that demonstrate T1 magnetic resonance pattern upon exposure to a magnetic field. Also...
|
|
|
8148352 |
Antimicrobial therapy for bacterial infections
The disclosure provides compounds and methods to treat bacterial pathogenesis, and demonstrates that the S. aureus pigment is a virulence factor and potential novel target for antimicrobial therapy.
|
|
|
8147872 |
Pharmaceutical compositions of drugs and neutralized acidic polymers
Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
|
|
|
8147874 |
Coated pellets
Coated pellets which comprise an active pharmaceutical ingredient that is poorly soluble in water, release at least 80% of the active ingredient under in vitro conditions in phosphate buffer at pH...
|
|
|
8147873 |
Methods and compositions for treatment of ion imbalances
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical...
|